Within four months, the US went from zero GLP-1 pills for weight management to two. The Wegovy pill (oral semaglutide) was approved December 22, 2025 and hit pharmacies in January. Foundayo (orforglipron), Lilly's pill, was approved April 1, 2026. For the roughly one in four adults with some degree of needle aversion, this is the moment many were waiting for.
But “pill” is doing a lot of work in that sentence, because the two pills ask very different things of your day. And whether switching makes sense for you is a prescriber decision that depends on your history, your routine, and your coverage. Here's what's verified, and what to ask.
The practical differences, verified
- The Wegovy pill has a strict morning ritual. First thing in the morning, empty stomach, with no more than 4 ounces of plain water, then a 30-minute wait before eating, drinking, or taking other oral medications. If your mornings include coffee at 6am and thyroid medication, that wait belongs in the conversation with your doctor.
- Foundayo has no food or water restrictions. Any time of day. Lilly positions that as its core difference.
- Switching isn't automatic. Moving from Wegovy injections to the Wegovy pill is the same molecule, and guidance involves timing around your last injection. Moving to a different molecule, like from Zepbound to Foundayo, typically means starting lower and titrating up again. How your switch would be sequenced is exactly the kind of question your prescriber is for.
- Absorption can differ person to person. Clinicians have noted that some patients absorb oral semaglutide differently than the injectable. Another reason the switch deserves a monitored plan rather than a pharmacy swap.
Cost and coverage, as of mid-2026
Self-pay through NovoCare: the Wegovy pill runs $149 a month at lower strengths and $299 at higher ones. Foundayo starts around $149 self-pay, and can be $25 a month with a commercial-insurance savings card. Both pills are included in Medicare's $50 GLP-1 Bridge that started July 1, 2026. One thing insurance folks keep pointing out: your plan may treat the pill and the injectable differently, so a denial on one is not automatically a denial on the other. That cuts both ways, and it's worth a specific question to your insurer.
The questions for the switching conversation
- Given my history and current dose, am I a candidate for either pill? Which one fits my routine?
- How would we sequence the switch from my current medication, and over how long?
- What should I watch during the transition, and when would you want to see me?
- If the pill doesn't agree with me, what's the path back?
- How does my coverage treat the pill vs the injectable? Does the prior authorization transfer?
- Do any of my other morning medications conflict with the Wegovy pill's fasting window?
Walk in with your dose timeline and how the current medication has been going, on one page. A switching conversation built on your actual history takes ten minutes. One built on memory takes the whole visit. The free Appointment Prep Kit has the template.
Quick answers
Is there a pill version of Wegovy or Ozempic?
Yes. The Wegovy pill (oral semaglutide) was FDA approved December 22, 2025 for weight management. A second pill, Foundayo (orforglipron), was approved April 1, 2026. Both are available in US pharmacies as of mid-2026.
Do you have to take the Wegovy pill on an empty stomach?
Yes. It's taken first thing in the morning on an empty stomach with no more than 4 ounces of plain water, followed by a 30-minute wait before eating, drinking, or other oral medications. Foundayo has no food or water restrictions.
Can I switch from GLP-1 injections to the pill?
Many people can, but the path depends on which medication you're on. Same-molecule switches (Wegovy shot to Wegovy pill) are sequenced around your last injection. Different-molecule switches usually restart at a lower dose. Ask your prescriber how they'd plan yours.
How much does the Wegovy pill or Foundayo cost without insurance?
As of mid-2026: the Wegovy pill is $149/month self-pay at lower strengths and $299 at higher strengths through NovoCare. Foundayo starts around $149 self-pay, or $25/month with a commercial-insurance savings card. Both are in Medicare's $50 Bridge program.
Will insurance cover the pill if it denied the injection?
Possibly. Plans can treat the pill and injectable differently on formulary, so a denial on one doesn't automatically apply to the other. Ask your insurer specifically about the oral version, in writing.